USPTO serial 98768647
OPDNA
Reviewed by CopyMark Law Group
Status 730Notice of Allowance
- Filing date
- Status date
- Registration date
- —
- Examiner
- DEMARCO,JOE P
- Law office
- INTENT TO USE SECTION
What this means
The USPTO has issued a Notice of Allowance. To complete registration you generally need to file a Statement of Use or an extension request before the deadline.
Need help with OPDNA?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Notice of Allowance, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $549*
Plus Government fees of $600
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Cambridgeshire, GB
Cambridgeshire, GB
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Andrew J. Avsec
P.O. Box 10395Chicago, IL 60610United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | reagents for research and scientific purposes, namely, chemical, biochemical, biological, and biotechnological reagents for laboratory use in the fields of life science, biotechnology and genomics; reagents for scientific purposes, namely, laboratory reagents for scientific use in the fields of life science, biotechnology and genomics; diagnostic reagents for scientific purposes, namely, diagnostic reagents for scientific use in the fields of life science, biotechnology and genomics; diagnostic preparations used in science, namely, diagnostic preparations for scientific use in the fields of life science, biotechnology and genomics; enzyme preparations for industrial purposes; enzymes for industrial purposes; industrial chemicals; biochemical catalysts; diagnostic preparations, other than for medical or veterinary purposes; biological preparations for use in industry and science, other than for medical or veterinary purposes; proteins in raw material form for scientific research, namely, proteins for use in recombinant DNA technology, other than for medical use; proteins in raw material form for medical research, namely, proteins for use in recombinant DNA technology for use in medical laboratories | ACTIVE | — |
| 005 | Chemicals, namely, chemical preparations and chemical reagents for medical purposes, to be used in medical laboratories and for medical diagnostic purposes; diagnostic preparations for medical purposes, namely, diagnostic preparations for use in medical laboratories and for medical diagnostic purposes; medical diagnostic reagents, namely, diagnostic reagents for use in medical laboratories and for medical diagnostic purposes; reagents for medical use, namely, biochemical, biological, and biotechnological reagents for use in medical laboratories and for medical diagnostic purposes; diagnostic preparations for medical purposes, namely, biochemical, biological, and biotechnological preparations for medical diagnostic purposes; vaccine preparations | ACTIVE | — |
| 009 | Scientific laboratory research instruments for measuring, analyzing and quantifying chemical, biochemical and biological components for genomic and nucleic acid research; scientific apparatus and instruments for the detection and analysis of nucleic acids; scientific research kits for measuring, analyzing, and quantifying chemical, biochemical, and biological components for genomic and nucleic acids research primarily comprised of thermometers not for medical purposes, test tubes, spectrometers, chromatographs and chromatography systems, mass spectrometers, DNA analyzers, electrochemical monitors for laboratory use, DNA sequencers, electrophoresis instruments not for medical purposes, DNA extractors; computer software applications, downloadable for manufacturing and research in the field of synthetic DNA and RNA design and synthesis, non-viral vector development, process control and data analysis in the field of medical research; material testing instruments and machines, namely, electronic apparatus for testing synthetic DNA and RNA and non-viral vectors; testing apparatus not for medical purposes, namely, recombinant DNA technology testing machines in the fields of DNA synthesis, non-viral vectors, and payload delivery; diagnostic apparatus, not for medical purposes, namely, diagnostic apparatus for testing synthetic DNA and RNA; chemistry apparatus and instruments, namely, flasks for laboratory use, electronic chemical analyzers for testing and analyzing chemical substances for the presence, absence, or quantity of target chemicals, chemistry apparatus for detecting and analysing DNA and RNA, not for medical purposes; DNA chips; surveying apparatus and instruments; laboratory bioreactors; genetic testing apparatus for scientific use, namely, laboratory devices for detecting genetic sequences; laboratory apparatus for detecting genetic sequences | ACTIVE | — |
| 042 | Laboratory research services in the fields of life science, biotechnology and genomics; scientific research services for others in the fields of life science, biotechnology and genomics; biological, biotechnological, chemical and biochemical research in the fields of life science, biotechnology and genomics; biological analysis in the fields of life science, biotechnology and genomics; chemical analysis in the fields of life science, biotechnology and genomics; biochemical analysis in the fields of life science, biotechnology and genomics; biological, biotechnological, chemical and biochemical development services in the fields of life science, biotechnology and genomics, namely, development of synthetic DNA and RNA and non-viral vectors; contract research services for others in the fields of life science, biotechnology and genomics; genomics research and analysis, namely, analysis and research of nucleic acids; scientific research and development in the field of nucleic acids; research and development in the field of genomics for drugs and pharmaceutical discovery and research; consulting services in the field of genetic science, namely, consultancy services relating to nucleic acids and genomics; genomics research services, namely, research services in the field of nucleic acids for therapeutic and diagnostic use; scientific services, namely, design in the field of genetics being design of synthetic DNA, genes and oligonucleotides for others; scientific research in the field of genetics; research and development services in the field of genomics; research and development of vaccines and medicines | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by 4BASEBIO PLC
- Other trademarks owned by 4BASEBIO PLC
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 009
- Other trademarks in Class 042
- Similar marks named OPDNA
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Apr 22, 2026 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Apr 21, 2026 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Apr 21, 2026 | EXT1 | SOU EXTENSION 1 FILED | — |
| Apr 21, 2026 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Nov 4, 2025 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Sep 9, 2025 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Sep 9, 2025 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Sep 3, 2025 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Aug 12, 2025 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Aug 11, 2025 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Aug 11, 2025 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Aug 11, 2025 | ERSI | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED | — |
| Aug 7, 2025 | GNS3 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | — |
| Aug 7, 2025 | GNSL | LETTER OF SUSPENSION E-MAILED | — |
| Aug 7, 2025 | CNSL | SUSPENSION LETTER WRITTEN | — |
| Jun 24, 2025 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jun 23, 2025 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jun 23, 2025 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Mar 24, 2025 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 24, 2025 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 24, 2025 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 18, 2025 | DOCK | ASSIGNED TO EXAMINER | — |
| Sep 25, 2024 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Sep 25, 2024 | NWAP | NEW APPLICATION ENTERED | — |